Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03402672 · ClinicalTrials.gov registry record · NA
AWAITS: A Web-based E-health Application for Active Illicit Opioid Users
A NA study of Opioid Use Disorder and Substance Use Disorders, sponsored by University of Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT03402672: Completed NA study of Opioid Use Disorder and Substance Use Disorders, sponsored by University of Cincinnati.
NCT03402672 is a NA study of Opioid Use Disorder and Substance Use Disorders that has completed, run by University of Cincinnati. The registered enrollment target is 24 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03402672, a NA study of Opioid Use Disorder and Substance Use Disorders, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to: 1. assess how participants like the AWAITS e-health application as measured by their feedback on the intervention 2. test the impact of AWAITS on knowledge about opioid overdose and risk-reduction strategies. 3. assess the proportion of participants who accept a list of local treatment providers 4. test the impact of AWAITS on interest in being tested for HCV/HIV.
Primary Outcome
To test the impact of AWAITS on knowledge about opioid overdose
Conditions Studied
Interventions
- OTHER self-administered, e-health application
Study Locations (1)
Ohio
- University of Cincinnati Addiction Sciences Division - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2017-11-08 |
| Est. Completion | 2018-06-21 |
| Phase | NA |
What the finished NCT03402672 record still lists
NCT03402672 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower).
The record links to 5 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which self-administered, e-health application is the first listed.
NCT03402672 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03402672 about?
NCT03402672 is a clinical study titled "AWAITS: A Web-based E-health Application for Active Illicit Opioid Users". The purpose of this research study is to: 1. assess how participants like the AWAITS e-health application as measured by their feedback on the intervention 2. test the impact of AWAITS on knowledge about opioid overdose and risk-reduction strategies. 3. assess the proportion of participants who acc...
What is the current status of trial NCT03402672?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2017-11-08. Estimated completion is 2018-06-21.
What conditions does trial NCT03402672 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Substance Use Disorders, Drug Addiction, Overdose, IV Drug Usage.
What interventions are being tested in trial NCT03402672?
The interventions under investigation include: self-administered, e-health application (OTHER).
Who is sponsoring clinical trial NCT03402672?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03402672 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03402672's enrollment target sits among peer trials
24 222nd of 257 higher than 31 of 257 other Opioid Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI